S. Bellentani

A. Gasbarrini, G. Marchesini, A. Lonardo, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma

F. Piscaglia, C. Tiribelli, S. Bellentani, 2016, Clinical liver disease.

ASH and NASH

G. Bedogni, S. Bellentani, M. Marino, 2011, Digestive Diseases.

Epidemiology of hepatocellular carcinoma in metabolic liver disease

S. Bellentani, 2020, Hepatoma Research.

The spectrum of liver disease in the general population: lesson from the Dionysos study.

C. Tiribelli, S. Bellentani, 2001, Journal of hepatology.

Risk factors for alcoholic liver disease

M. Giacca, C. Tiribelli, S. Bellentani, 2000, Addiction biology.

The epidemiology of non‐alcoholic fatty liver disease

S. Bellentani, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial.

F. Callea, C. Tiribelli, S. Bellentani, 1993, Journal of hepatology.

Specificity of an Na+ -dependent taurocholate transport site in isolated rat hepatocytes.

S. Bellentani, W. Hardison, D. Shellhamer, 1984, The American journal of physiology.

Sex steroid modulation of the hepatic uptake of organic anions in rat.

C. Tiribelli, S. Bellentani, M. Persico, 1988, Journal of hepatology.

Bile acid inhibition of taurocholate uptake by rat hepatocytes: role of OH groups.

S. Bellentani, W. Hardison, P. Marchegiano, 1987, The American journal of physiology.

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence

S. Bellentani, A. Colletti, A. Cicero, 2018, Nutrients.

Is there an effective therapy available for non-alcoholic fatty liver disease?

S. Bellentani, Vittorio di Maso, Vittorio Di Maso, 2009, F1000 medicine reports.

Fatty liver: how frequent is it and why?

G. Bedogni, S. Bellentani, 2004, Annals of hepatology.

Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?

A. Lonardo, S. Bellentani, V. Ratziu, 2011, Expert review of gastroenterology & hepatology.

Alcohol-induced liver disease: from molecular damage to treatment.

C. Tiribelli, S. Bellentani, José C Fernández Checa, 2002, Revista medica de Chile.

Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

N. Milić, S. Bellentani, A. De Lorenzo, 2014, World journal of gastroenterology.

Natural Course of Chronic HCV and HBV Infection and Role of Alcohol in the General Population: The Dionysos Study

G. Bedogni, C. Tiribelli, A. Granito, 2008, The American Journal of Gastroenterology.

676 The fatty liver index: A simple and accurate predictor of hepatic steatosis

G. Bedogni, S. Bellentani, L. Miglioli, 2006 .

PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: perspectives in the diagnosis of pancreatic cancer.

G. Bedogni, S. Saccomanno, A. Benedetti, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Nonalcoholic Fatty Liver Disease: A Wide Spectrum Disease

S. Bellentani, N. Rosso, 2020 .

Taurine increases bile acid pool size and reduces bile saturation index in the hamster.

E. Bosisio, S. Bellentani, E. De Fabiani, 1987, Journal of lipid research.

Cow’s Milk Consumption and Health: A Health Professional’s Guide

C. la Vecchia, P. Magni, M. Brandi, 2018, Journal of the American College of Nutrition.

Moderate alcohol use and health: A consensus paper

R. Sterzi, A. Avogaro, D. Rizzoni, 2013 .

Liver and heart: a new link?

G. Bedogni, C. Tiribelli, S. Bellentani, 2008, Journal of hepatology.

Liver and heart : A new link ? q

G. Bedogni, C. Tiribelli, S. Bellentani, 2008 .

Is it time to change NAFLD and NASH nomenclature?

C. Tiribelli, S. Bellentani, 2017, The lancet. Gastroenterology & hepatology.

Substantial variability of the diagnostic accuracy of serum fibrosis markers across multiple cohorts of nash patients in various centers : the case for the negative predictive value

G. Marchesini, J. Dufour, P. Bedossa, 2015 .

Modulation of liver-specific cellular response to ethanol in vitro in hep G2 cells.

R. Cameron, C. Tiribelli, S. Bellentani, 1998, Toxicology in vitro : an international journal published in association with BIBRA.

Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line.

R. Cameron, C. Tiribelli, S. Bellentani, 1995, Gastroenterology.

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

G. Bedogni, A. Gastaldelli, C. Tiribelli, 2018, BMC Gastroenterology.

Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins.

C. Tiribelli, S. Bellentani, M. Stebel, 1992, Biochemical and biophysical research communications.

Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?

S. Bellentani, L. Abenavoli, 2013, Expert review of gastroenterology & hepatology.

HCV, HBV and Alcohol – the Dionysos Study

G. Bedogni, C. Tiribelli, S. Bellentani, 2011, Digestive Diseases.

Correlation between bromodeoxyuridine labelling and ornithine decarboxylase levels in normal rectal mucosa of patients with colorectal adenoma.

G. Brandi, S. Bellentani, M. Ponz de Leòn, 1991, Cancer letters.

The effect of etofibrate on cholesterol and bile acid metabolism in the hamster.

E. Bosisio, S. Bellentani, E. De Fabiani, 1989, Pharmacological research.

Effect of tauroursodeoxycholate feeding, with or without taurine supplementation on hepatic bile acids and cholesterol metabolism in the hamster.

E. Bosisio, S. Bellentani, E. De Fabiani, 1987, Pharmacological research communications.

Doppler perfusion index (DPI) and homa are highly predictive of fatty liver in patients with NAFLD

N. Battistini, G. Bedogni, S. Bellentani, 2008 .

902 DOPPLER PERFUSION INDEX (DPI) IS HIGHLY PREDICTIVE OF THE GRADE OF FATTY LIVER IN OVERWEIGHT PATIENTS WITH NAFLD

N. Battistini, S. Bellentani, L. Miglioli, 2008 .

The management of patients with new onset of upper gastro-intestinal symptoms in primary care.

S. Bellentani, C. Tosetti, F. Cardin, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

SUSCEPTIBILITY OF CHRONIC SYMPTOMLESS HBsAg CARRIERS TO ETHANOL-INDUCED HEPATIC DAMAGE

S. Bellentani, E. Villa, F. Manenti, 1982, The Lancet.

Familial clustering of Helicobacter pylori infection: population based study.

P. Dominici, E. Grossi, C. Tiribelli, 1999, BMJ.

BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared

S. Bellentani, F. Balli, M. Rinaldi, 1984, European Journal of Pediatrics.

Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study

C. Tiribelli, S. Bellentani, G. Saccoccio, 1994, Hepatology.

Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?

S. Bellentani, 2005, European journal of gastroenterology & hepatology.

Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial.

S. Bellentani, E. Villa, F. Manenti, 1989, Journal of hepatology.

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.

M. Manns, F. Tacke, C. Trautwein, 2018, Journal of hepatology.

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

F. Piscaglia, G. Svegliati-Baroni, C. Tiribelli, 2016, Hepatology.

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

C. Byrne, A. Lonardo, H. Cortez‐Pinto, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

C. Tiribelli, S. Bellentani, M. Lenzi, 1999, Gut.

Epidemiology of Non-Alcoholic Fatty Liver Disease

G. Bedogni, S. Bellentani, Stefano Bellentani, 2010, Digestive Diseases.

Ethanol‐induced increase in cytosolic estrogen receptors in human male liver: A possible explanation for biochemical feminization in chronic liver disease due to alcohol

G. Rossini, S. Bellentani, M. Melegari, 1988, Hepatology.

Bile-acid binding to isolated rat liver plasma membranes. Failure to find a specific binding site.

S. Bellentani, W. Hardison, F. Manenti, 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

Estrogens keep alive the hepatocyte memory

C. Tiribelli, S. Bellentani, 1988, Hepatology.

Role of MIF in Hepatic Inflammatory Diseases and Fibrosis

R. Bataller, C. Tiribelli, S. Bellentani, 2017 .

Microbiota, NASH, HCC and the potential role of probiotics

M. Candela, G. Brandi, F. Tovoli, 2017, Carcinogenesis.

Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells.

C. Tiribelli, S. Bellentani, N. Shear, 1998, Gastroenterology.

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

R. Dalle Grave, G. Marchesini, S. Bellentani, 2007, Hepatology.

Alcohol and Nutrition as Risk Factors for Chronic Liver Disease

G. Bedogni, C. Tiribelli, S. Bellentani, 2013 .

DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study.

C. Tiribelli, F. Farinati, S. Bellentani, 2001, Journal of hepatology.

Predictors of non-alcoholic fatty liver disease in obese children

G. Bedogni, C. Tiribelli, S. Bellentani, 2007, European Journal of Clinical Nutrition.

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions.

G. Marchesini, F. Piscaglia, A. Gastaldelli, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The role of calcium precipitation in the sulfoglycolithocholate-induced cholestasis of the bile fistula hamster.

A. Angeloni, S. Bellentani, G. Saccoccio, 1990, Journal of hepatology.

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

C. Tiribelli, S. Bellentani, F. Masutti, 1999, Gut.

Drinking habits as cofactors of risk for alcohol induced liver damage

G. Brandi, C. Tiribelli, S. Bellentani, 1997, Gut.

High Prevalence of Celiac Disease in Italian General Population

G. Brandi, L. De Franceschi, C. Tiribelli, 2001, Digestive Diseases and Sciences.

Moderate alcohol use and health: a consensus document.

R. Sterzi, C. la Vecchia, A. Avogaro, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Chris Day, Giulio Marchesini, G. Marchesini, 2010, Journal of hepatology.

A "systems medicine" approach to the study of non-alcoholic fatty liver disease.

S. Bellentani, G. Targher, E. Bugianesi, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Sex differences in the hepatic uptake of sulphobromophthalein in the rat.

C. Tiribelli, S. Bellentani, P. Simoni, 1985, Clinical science.

Mechanisms of liver adaptation to prolonged selective biliary obstruction (SBO) in the rat.

S. Bellentani, W. Hardison, F. Manenti, 1985, Journal of hepatology.

Study of the long-term effects of selective biliary obstruction (SBO)

S. Bellentani, E. Villa, A. Ferrari, 1981, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

From NAFLD in clinical practice to answers from guidelines.

Fabio Nascimbeni, A. Lonardo, S. Bellentani, 2013, Journal of hepatology.

Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).

S. Bellentani, M. Marino, 2009, Annals of hepatology.

Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.

G. Marchesini, A. Lonardo, S. Bellentani, 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Body Mass Index: from Quételet to evidence-based medicine

G. Bedogni, C. Tiribelli, S. Bellentani, 2006 .

Interaction of alcohol intake and cofactors on the risk of cirrhosis

S. Bellentani, G. Addolorato, C. Loguercio, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Viewpoint: "Alcohol Consumption in Late Adolescence is Associated with an Increased Risk of Severe Liver Disease Later in Life".

S. Bellentani, A. Tamburello, Marco Marando, 2018, Annals of hepatology.

Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery.

C. Tiribelli, S. Bellentani, L. Miglioli, 2000, Microbes and infection.

External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study

G. Bedogni, A. Gastaldelli, C. Tiribelli, 2021, Journal of clinical medicine.

Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats.

C. Tiribelli, S. Bellentani, I. Ferretti, 1996, Biochemical and Biophysical Research Communications - BBRC.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Chris Day, Fritz Wrba, Debbie Lawlor, 2016, Alimentary pharmacology & therapeutics.

Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

C. Tiribelli, S. Bellentani, N. Chavez-Tapia, 2014, World journal of gastroenterology.

Incidence and natural course of fatty liver in the general population: The Dionysos study

G. Bedogni, C. Tiribelli, S. Bellentani, 2007, Hepatology.

Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future

G. Bedogni, C. Tiribelli, S. Bellentani, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Nonalcoholic fatty liver disease burden - Switzerland 2018-2030.

F. Negro, J. Dufour, D. Semela, 2019, Swiss medical weekly.

Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?

G. Bedogni, A. Gastaldelli, C. Tiribelli, 2020, Annals of hepatology.

Mechanisms of Transport of Tauroconjugated Bile Acids in the Hepatocyte: Functional Significance

S. Bellentani, W. Hardison, F. Manenti, 1987 .

Body mass index is a good predictor of an elevated alanine transaminase level in the general population: hints from the Dionysos study.

N. Battistini, G. Bedogni, C. Tiribelli, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD).

M. Malavolti, N. Battistini, A. Lonardo, 2013, Clinics and research in hepatology and gastroenterology.

[700] INCIDENCE, REMISSION AND MORTALITY RATE OF FATTY LIVER IN THE DIONYSOS COHORT

G. Bedogni, C. Tiribelli, S. Bellentani, 2007 .

Hepatitis B virus markers on dried blood spots. A new tool for epidemiological research.

S. Bellentani, R. Cartolari, E. Villa, 1981, Journal of clinical pathology.

Obesity and not alcohol intake is the main cause of liver steatosis

C. Tiribelli, S. Bellentani, F. Masutti, 1998 .

THE ONCOGENICITY OF AZATHIOPRINE ?

C. Tiribelli, S. Bellentani, Tage‐Jensen, 2022 .

Editorial: The North-to-South Gradient of Hepatitis C Virus Infection

C. Tiribelli, S. Bellentani, C. Campello, 2003, Scandinavian journal of gastroenterology.

Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD.

M. Malavolti, N. Battistini, S. Bellentani, 2012, Frontiers in bioscience.

Genetic Determinants of Ethanol-Induced Liver Damage

M. Giacca, C. Tiribelli, S. Bellentani, 2001, Molecular medicine.

External validation of biomarkers of fatty liver in the general population: the Bagnacavallo study

G. Bedogni, A. Gastaldelli, C. Tiribelli, 2020 .

PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: perspectives in the diagnosis of pancreatic cancer.

G. Bedogni, S. Saccomanno, A. Benedetti, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.

M. Manns, F. Tacke, C. Trautwein, 2018, Journal of hepatology.

From NAFLD in clinical practice to answers from guidelines.

A. Lonardo, S. Bellentani, F. Nascimbeni, 2013, Journal of hepatology.

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions.

G. Marchesini, F. Piscaglia, A. Gastaldelli, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Contents Vol. 28, 2010

S. Dooley, G. Bedogni, C. Hellerbrand, 2011, Digestive Diseases.

review Microbiota, NASH, HCC and the potential role of probiotics

S. Bellentani, M. Pantaleo, G. Saccoccio, 2022 .